Full analysis of belimumab side effects: identifying symptoms and coping strategies

Belimumab , as a specific inhibitor ofB lymphocyte stimulating factor (BLyS), brings new treatment hope to patients with active systemic lupus erythematosus (SLE) and active lupus nephritis. However, like all drugs, belimumab may be associated with a range of side effects, some of which may be life-threatening. Therefore, it is important for patients to understand the side effects of belimumab and how to manage them.

The most common side effects include nausea, diarrhea, fever, stuffy or runny nose and sore throat (nasopharyngitis), persistent cough (bronchitis), sleep disturbance (insomnia), leg or arm pain, depression, and headache (migraine). In addition, patients may experience pain, redness, itching, or swelling at the injection site during subcutaneous injections. Most of these side effects are mild and may gradually lessen or disappear as treatment progresses.

However, belimumab can also cause serious side effects. Among them, infectious diseases are a problem that requires high vigilance. Infections can be serious and even lead to hospitalization or death. If patients develop symptoms such as fever, chills, pain or burning when urinating, frequent urination, coughing up mucus, or hot, red, or painful skin or ulcers on their body, they should inform medical staff immediately for prompt diagnosis and treatment.

Anaphylaxis is also a possible serious side effect of belimumab treatment. Severe allergic reactions may occur on the day you receive the drug or several days afterward and can be life-threatening. Patients who develop symptoms such as swelling of the face, lips, mouth, tongue, or throat, difficulty breathing, anxiety, hypotension, dizziness or fainting, headache, nausea, and rash should seek medical attention immediately and receive close observation and treatment by medical staff.

In addition, belimumab may also have an impact on patients' mental health, leading to an increased risk of suicide. Patients should pay close attention to changes in their mood and behavior, such as thoughts of suicide or death, suicide attempts, sleep disturbances, new or worse symptoms of anxiety, depression, and acting on dangerous impulses, and should seek help and support from medical personnel immediately.

Patients should also be alert to rare but serious side effects such as progressive multifocal leukoencephalopathy (PML) and cancer. If you experience symptoms such as memory loss, difficulty thinking, dizziness or loss of balance, difficulty speaking or walking, blindness, or suspected signs of cancer, you should seek medical attention immediately and undergo relevant examinations.

Facing the side effects of belimumab, patients should maintain a positive attitude, follow the doctor's guidance, use medications rationally, and pay close attention to their body's reaction. Once any discomfort or abnormal symptoms occur, medical staff should be informed immediately so that the treatment plan can be adjusted in a timely manner to ensure the health and safety of the patient. At the same time, patients should also enhance their body's resistance and immunity through good living habits and mentality adjustments to better cope with the challenges during treatment.

Reference: https://www.drugs.com/benlysta.html